KDM5A is highly expressed in drug-resistant cells such as temozolomide (TMZ)-resistant glioblastoma cells, and CPI-455 is more effective in TMZ-resistant glioblastoma cells than in TMZ-native cells [106]. This evidence concerns the gene KDM5A and glioblastoma.